Nurix Therapeutics, Inc. NRIX Unrealized Gains on Investments
Unrealized Gains on Investments at other companies
Other financials
Where this comes from
Reported directly by Nurix Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax.
The official record: Nurix Therapeutics, Inc.’s 10-Q, filed April 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nurix Therapeutics, Inc.'s unrealized gains on investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Nurix Therapeutics, Inc.'s unrealized gains on investments?
- Nurix Therapeutics, Inc. (NRIX) reported unrealized gains on investments of $88K in Q4 2025.
- What does unrealized gains on investments mean?
- This represents the cumulative positive change in the fair value of available-for-sale investment securities compared to their original cost basis. It reflects potential gains that have not yet been realized through the sale of the assets. For a biopharmaceutical company, this indicates the performance of the treasury portfolio and the unrealized appreciation of liquid assets.